These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 17170081)

  • 1. The hormone replacement therapy drug tibolone acts very similar to medroxyprogesterone acetate in an estrogen-and progesterone-responsive endometrial cancer cell line.
    Hanifi-Moghaddam P; Sijmons B; Ott MC; van Ijcken WF; Nowzari D; Kuhne EC; van der Spek P; Kloosterboer HJ; Burger CW; Blok LJ
    J Mol Endocrinol; 2006 Dec; 37(3):405-13. PubMed ID: 17170081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in protein tyrosine phosphatase type IVA member 1 and zinc finger protein 36 C3H type-like 1 expression demonstrate altered estrogen and progestin effect in medroxyprogesterone acetate-resistant and estrogen-independent breast cancer cell models.
    Pennanen PT; Sarvilinna NS; Purmonen SR; Ylikomi TJ
    Steroids; 2009; 74(4-5):404-9. PubMed ID: 19146866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-alpha mRNA in Ishikawa cells. Implication for tibolone's effects on the endometrium.
    Mirkin S; Archer DF
    Maturitas; 2007 Aug; 57(4):338-46. PubMed ID: 17478063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular portrait of the progestagenic and estrogenic actions of tibolone: behavior of cellular networks in response to tibolone.
    Hanifi-Moghaddam P; Gielen SC; Kloosterboer HJ; De Gooyer ME; Sijbers AM; van Gool AJ; Smid M; Moorhouse M; van Wijk FH; Burger CW; Blok LJ
    J Clin Endocrinol Metab; 2005 Feb; 90(2):973-83. PubMed ID: 15572424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of human endometrium: short-term tibolone signaling differs significantly from estrogen and estrogen + progestagen signaling.
    Hanifi-Moghaddam P; Boers-Sijmons B; Klaassens AH; van Wijk FH; den Bakker MA; Ott MC; Shipley GL; Verheul HA; Kloosterboer HJ; Burger CW; Blok LJ
    J Mol Med (Berl); 2007 May; 85(5):471-80. PubMed ID: 17226044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progestins regulate genes that can elicit both proliferative and antiproliferative effects in breast cancer cells.
    Purmonen S; Manninen T; Pennanen P; Ylikomi T
    Oncol Rep; 2008 Jun; 19(6):1627-34. PubMed ID: 18497975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells.
    Courtin A; Communal L; Vilasco M; Cimino D; Mourra N; de Bortoli M; Taverna D; Faussat AM; Chaouat M; Forgez P; Gompel A
    Breast Cancer Res Treat; 2012 Jan; 131(1):49-63. PubMed ID: 21336598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progestogenic effects of tibolone on human endometrial cancer cells.
    Blok LJ; De Ruiter PE; Kühne EC; Hanekamp EE; Grootegoed JA; Smid-Koopman E; Gielen SC; De Gooyer ME; Kloosterboer HJ; Burger CW
    J Clin Endocrinol Metab; 2003 May; 88(5):2327-34. PubMed ID: 12727992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct functional differences of human progesterone receptors A and B on gene expression and growth regulation in two endometrial carcinoma cell lines.
    Smid-Koopman E; Blok LJ; Kühne LC; Burger CW; Helmerhorst TJ; Brinkmann AO; Huikeshoven FJ
    J Soc Gynecol Investig; 2003 Jan; 10(1):49-57. PubMed ID: 12517594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequences of loss of progesterone receptor expression in development of invasive endometrial cancer.
    Hanekamp EE; Gielen SC; Smid-Koopman E; Kühne LC; de Ruiter PE; Chadha-Ajwani S; Brinkmann AO; Grootegoed JA; Burger CW; Huikeshoven FJ; Blok LJ
    Clin Cancer Res; 2003 Sep; 9(11):4190-9. PubMed ID: 14519645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional profiles of progestogen effects in the postmenopausal breast.
    Wood CE; Register TC; Cline JM
    Breast Cancer Res Treat; 2009 Mar; 114(2):233-42. PubMed ID: 18404370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
    Keramaris NC; Christodoulakos GE; Lambrinoudaki IV; Dalamanga A; Alexandrou AP; Bramis J; Bastounis E; Creatsas GC
    Climacteric; 2007 Oct; 10(5):400-7. PubMed ID: 17852143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tibolone and conventional HRT on the expression of estrogen and progesterone receptors in the breast.
    Ma L; Hofling M; Masironi B; von Schoultz B; Cline JM; Sahlin L
    Maturitas; 2008 Dec; 61(4):345-9. PubMed ID: 18980817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin.
    Odmark IS; Carlström K; Jonsson B; Jonasson AF
    Maturitas; 2006 Jan; 53(1):89-96. PubMed ID: 15964160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dependent changes of the ratio of apoptosis to proliferation by norethisterone and medroxyprogesterone acetate in human breast epithelial cells.
    Seeger H; Rakov V; Mueck AO
    Horm Metab Res; 2005 Aug; 37(8):468-73. PubMed ID: 16138258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 17 beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells.
    Mirkin S; Wong BC; Archer DF
    Fertil Steril; 2005 Aug; 84(2):485-91. PubMed ID: 16084894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and structural basis of androgen receptor responses to dihydrotestosterone, medroxyprogesterone acetate and Δ(4)-tibolone.
    Bianco-Miotto T; Trotta AP; Need EF; Lee AM; Ochnik AM; Giorgio L; Leach DA; Swinstead EE; O'Loughlin MA; Newman MR; Birrell SN; Butler LM; Harris JM; Buchanan G
    Mol Cell Endocrinol; 2014 Feb; 382(2):899-908. PubMed ID: 24239616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene regulation profiles by progesterone and dexamethasone in human endometrial cancer Ishikawa H cells.
    Davies S; Dai D; Pickett G; Leslie KK
    Gynecol Oncol; 2006 Apr; 101(1):62-70. PubMed ID: 16289307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difference in signalling between various hormone therapies in endometrium, myometrium and upper part of the vagina.
    Hanifi-Moghaddam P; Boers-Sijmons B; Klaassens AH; van Wijk FH; Van Ijcken WF; Van der Spek P; Verheul HA; Kloosterboer HJ; Burger CW; Blok LJ
    Hum Reprod; 2008 Feb; 23(2):298-305. PubMed ID: 18077316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis and proliferation in breast cancer cells, cultured in vitro: effects of SERMs.
    Werner HM; Franke HR; Vermes I
    Climacteric; 2005 Sep; 8(3):294-9. PubMed ID: 16390761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.